Dec 16, 2025 03:57AM
Dec 15, 2025 07:30PM
Nov 13, 2025 07:00AM
Nov 13, 2025 07:00AM
Oct 28, 2025 07:01AM
Oct 28, 2025 07:01AM
Oct 8, 2025 12:58PM Aldeyra Therapeutics (ALDX) PT Raised to $7 at Jefferies
Aug 28, 2025 07:02AM
Aug 28, 2025 07:01AM
Aug 19, 2025 07:01AM
Aug 19, 2025 07:01AM
Aug 8, 2025 12:20PM
Jul 24, 2025 07:01AM
Jul 24, 2025 07:00AM Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa
Jul 17, 2025 07:02AM
Jul 17, 2025 07:00AM
Jun 26, 2025 08:18AM
Jun 26, 2025 07:00AM
Jun 26, 2025 07:00AM
Jun 18, 2025 03:02PM
Jun 17, 2025 07:02AM Aldeyra Therapeutics (ALDX) Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Jun 17, 2025 07:00AM
May 18, 2025 10:00AM
May 13, 2025 01:22PM
May 9, 2025 08:00AM
May 6, 2025 07:08AM
May 5, 2025 06:34PM
May 5, 2025 02:12PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
May 4, 2025 08:18AM
May 2, 2025 03:33PM
May 1, 2025 03:18PM
Apr 30, 2025 07:36AM
Apr 29, 2025 11:16AM
Apr 28, 2025 07:11AM
Apr 26, 2025 07:08AM ALDX SHAREHOLDER ALERT: BFA Law Reminds Aldeyra Therapeutics, Inc. Investors of the Continuing Securities Investigation
Apr 25, 2025 12:57PM
Apr 24, 2025 07:36AM
Apr 22, 2025 07:17AM
Apr 21, 2025 02:30PM
Apr 20, 2025 07:37AM
Apr 18, 2025 03:23PM
Apr 17, 2025 03:11PM ALDX INVESTOR REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded to Contact BFA Law about the Securities Investigation
Apr 17, 2025 12:47PM
Apr 17, 2025 07:00AM
Apr 16, 2025 08:08AM
Apr 14, 2025 08:07AM
Apr 12, 2025 09:30AM
Apr 11, 2025 03:18PM
Apr 10, 2025 07:46AM ALDX CLASS REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded to Contact BFA Law about the Pending Securities Investigation
Apr 8, 2025 07:08AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All